First Time Loading...

Amicus Therapeutics Inc
NASDAQ:FOLD

Watchlist Manager
Amicus Therapeutics Inc Logo
Amicus Therapeutics Inc
NASDAQ:FOLD
Watchlist
Price: 10.43 USD 4.4% Market Closed
Updated: May 2, 2024

Amicus Therapeutics Inc
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Amicus Therapeutics Inc
Cash from Investing Activities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Amicus Therapeutics Inc
NASDAQ:FOLD
Cash from Investing Activities
$98.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
14%
Abbvie Inc
NYSE:ABBV
Cash from Investing Activities
-$2B
CAGR 3-Years
62%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Cash from Investing Activities
-$2.3B
CAGR 3-Years
46%
CAGR 5-Years
N/A
CAGR 10-Years
-24%
Amgen Inc
NASDAQ:AMGN
Cash from Investing Activities
-$26.2B
CAGR 3-Years
-69%
CAGR 5-Years
N/A
CAGR 10-Years
-12%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash from Investing Activities
-$3.1B
CAGR 3-Years
N/A
CAGR 5-Years
-73%
CAGR 10-Years
-50%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash from Investing Activities
-$3.2B
CAGR 3-Years
-256%
CAGR 5-Years
-17%
CAGR 10-Years
-25%

See Also

What is Amicus Therapeutics Inc's Cash from Investing Activities?
Cash from Investing Activities
98.1m USD

Based on the financial report for Dec 31, 2023, Amicus Therapeutics Inc's Cash from Investing Activities amounts to 98.1m USD.

What is Amicus Therapeutics Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
14%

Over the last year, the Cash from Investing Activities growth was 6%.